Oncternal Therapeutics, Inc. Annual Net Income (Loss) Attributable to Parent in USD from 2010 to 2023

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Oncternal Therapeutics, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2010 to 2023.
  • Oncternal Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$8.46M, a 14.2% increase year-over-year.
  • Oncternal Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$34.6M, a 17.1% increase year-over-year.
  • Oncternal Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$39.5M, a 10.6% increase from 2022.
  • Oncternal Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$44.2M, a 41% decline from 2021.
  • Oncternal Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$31.3M, a 81.9% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$39.5M +$4.69M +10.6% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-07
2022 -$44.2M -$12.8M -41% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-07
2021 -$31.3M -$14.1M -81.9% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-09
2020 -$17.2M +$17M +49.6% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-10
2019 -$34.2M -$27.6M -420% Jan 1, 2019 Dec 31, 2019 10-K/A 2021-03-12
2018 -$6.58M +$23.9M +78.4% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-16
2017 -$30.4M -$12.7M -71.7% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-18
2016 -$17.7M +$979K +5.23% Jan 1, 2016 Dec 31, 2016 10-K 2019-03-18
2015 -$18.7M +$20.7M +52.5% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-13
2014 -$39.4M +$2.7M +6.41% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-24
2013 -$42.1M -$15M -55.5% Jan 1, 2013 Dec 31, 2013 10-K 2016-03-15
2012 -$27.1M +$6.22M +18.7% Jan 1, 2012 Dec 31, 2012 10-K 2015-03-16
2011 -$33.3M -$48.6M -318% Jan 1, 2011 Dec 31, 2011 10-K 2014-03-12
2010 $15.3M Jan 1, 2010 Dec 31, 2010 10-K 2013-03-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.